trial · primary record
AVENIO ctDNA Surveillance Kit
Non-small Cell Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2027-12-30 |
| Primary endpoint | Decrease in ctDNA Level |
| Registry ID | NCT04585477 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:31.801Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04585477
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.